Type 1 diabetes: Evidence of interaction between ACP1 and ADA1 gene polymorphisms

Medical Science Monitor

Volumn 15, Issue 10, 2009, Pages

  Saccucci, Patrizia ^a   Bitti, Maria Luisa Manca ^a   Bottini, Nunzio ^a   Rapini, Novella ^a   Piccinini, Simona ^a   D'Annibale, Federica ^a   Chiarelli, Francesco ^b   Verrotti, Alberto ^b   Bottini, Egidio ^a   Gloria Bottini, Fulvia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

ACP1; ADA1; Genetic interaction; Type 1 diabetes

Indexed keywords

ACID PHOSPHATASE; ADENOSINE DEAMINASE; ACP1 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CAUCASIAN; CHILD; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; HEALTH; NEWBORN;

ADENOSINE DEAMINASE; ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HEALTH; HUMANS; INFANT, NEWBORN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS;

EID: 70349976998     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cardon LR, Palmer LJ: Population stratification and spurious allelic association. Lancet, 2003; 361: 598-604
2. Sing CF, Haviland MB, Reilly SL: Genetic architecture of common multifactorial diseases. Ciba Found Symp. 1996; 197: 211-229
3. Lucarini N, Borgiani P, Ballarini P, Bottini E: Erythrocyte acid phosphatase (ACP1) activity. In vitro modulation by adenosine and inosine and effects of adenosine deaminase (ADA) polymorphism. Hum Gen, 1989; 81: 185-187
4. Bottini N, Gloria-Bottini F, Borgiani P et al: Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms. Metabolism, 2004; 53: 995-1001
5. Nicotra M, Bottini N, La Torre M et al: Repeated spontaneous abortion. Cooperative effects of ADA and ACP1 genetic polymorphisms. Am J Reprod Immunol, 2007; 58: 1-10 (Pubitemid 46939022)
6. Lepore A, Lucarini N, Evangelista MA et al: Enzyme variability and neonatal jaundice. The role of adenosine deaminase and acid phosphatase. J Perinat Med, 1989; 17: 195-201 (Pubitemid 19249588)
7. Spencer N, Hopkinson A, Harris H: Quantitative differences and gene dosage in the human red cell phosphatase polymorphism. Nature, 1964; 201: 299-300
8. Bottini N, Stefanini L, Williams S et al: Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem, 2002; 277: 24220-24224 (Pubitemid 34951938)
9. Spencer N, Hopkinson D, Harris H: Adenosine deaminase polymorphism in man. Ann Hum Genet, 1968; 32: 9-14
10. Battistuzzi C, Scozzari R, Santolamazza P et al: Comparative activity of red cell adenosine deaminase allelic forms. Nature, 1974; 251: 712
11. Dong RP, Kameoka J, Hegen M et al: Characterisation of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol, 1996; 156: 1349-1355 (Pubitemid 26065841)
12. Danielsen AG, Liu F, Hosomi K et al: Activation of protein kinase C-alpha inhibits signalling by members of the insulin receptor family. J Biol Chem, 1995; 270: 21600-21605
13. Dent P, Reardon DB, Wood SL: Inactivation of raf-1 by a protein tyrosine phosphatase stimulated by GTP and reconstituted by GA1/0 subunits. J Biol Chem, 1996; 271: 3119-3123 (Pubitemid 26055612)
14. Reardon DB, Wood SL, Brautgan DL et al: Activation of a protein tyrosine phosphatise and inactivation of Raf-1 by somatostatin. Biochem J, 1996; 314: 401-404
15. Lazaruk KDA: Molecular genetics of human red cell acid phosphatase. PhD dissertation. Berkeley, CA. Prof. GF Sensabaugh, Chair, University of California, 1995
16. Kunkel LM, Smith KD, Boyer SH et al: Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA, 1977; 74: 1245-1249
17. Lattier DL, Hutton JJ: Complete sequence and structure of the gene for human adenosine deamination. Biochem, 1986; 25: 8234-8244 (Pubitemid 17233520)
18. Tzall S, Ellenbogen A, Eng F, Hirschhorn R: Identification and characterization of nine RFLP, at the adenosine deaminase (ADA) locus. Am J Hum Genet, 1989; 44: 864-875 (Pubitemid 19144445)
19. Hirschhorn R, Yang DR, Israni A: An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): Occurrence on different background and apparent intragenic crossover. Ann Hum Genet, 1994; 58: 1-9 (Pubitemid 24110508)
20. Nie NH, Hull CH, Jenkins JG et al: SPSS/PC+ version 5. Chicago: SPSS Inc., 1992
21. Sakaguchi N, Takahashi T, Hata H et al: Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature, 2003; 426: 454-460 (Pubitemid 37490133)
22. Stefani M, Caselli A, Bucciantini M et al: Dephosphorylation of tyrosine phosphorylated synthetic peptides by rat liver phosphotyrosine protein phosphatase isoenzymes. FEBS Lett, 1993; 326: 131-134 (Pubitemid 23200262)
23. Boivin P, Galand C: The human red cell acid phosphatase is a phosphotyrosine protein phosphatase which dephosphorylates the membrane protein band 3. Biochem Biophys Res Commun, 1986; 134: 557-564 (Pubitemid 16070534)
24. Low PS, Allen DP, Zioncheck TF et al: Tyrosine phosphorylation of band 3 inhibits peripheral protein binding. J Biol Chem, 1987; 262: 4592-4596
25. Fuchs KR, Shekels LL, Bernlohr DA: Analysis of the ACP1 gene product: classification as an FMN phosphatase. Biochem Biophys Res Commun, 1992; 189: 1598-1605
26. Xu B, Berkich DA, Crist GH, LaNoue KF: A1 adenosine receptor antagonism improves glucose tolerance in Zucker rats. Am J Physiol, 1998; 274: E271-79
27. Yasuda N, Inoue T, Horizoe T et al: Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes. Eur J Pharmacol, 2003; 459: 159-166 (Pubitemid 36078316)